Post-COVID Syndrome and Tachycardia: Theoretical Base and Treatment Experience

The coronavirus pandemic showed not only an increase in levels of excess morbidity and mortality in the acute phase, but also persisting symptoms 4 weeks after the onset of the disease. A review of international studies on the prevalence and diversity of the manifestations of postcoid syndrome is pr...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	V. I. Podzolkov, A. E. Bragina, A. I. Tarzimanova, L. V. Vasil'eva, E. P. Batrakova, N. V. Lobova, E. E. Bykova, M. M. Khachuroeva
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Столичная издательская компания 2021-05-01
סדרה:	Рациональная фармакотерапия в кардиологии
נושאים:	covid-19 post-covid syndrome postural orthostatic tachycardia syndrome if-channel inhibitor ivabradine
גישה מקוונת:	https://www.rpcardio.online/jour/article/view/2435
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!